NFKB1 and bipolar disorder: We also found that NF-κB-related mRNAs did not differ between bipolar disorder subjects as a function of treatment with antipsychotics (all F ≤ 3.1, all p ≥ 0.09; Supplemental Table S1), antidepressants (all F ≤ 3.4, all p ≥ 0.08), or benzodiazepines and/or valproic acid at time of death (all F ≤ 1.7, all p ≥ 0.20).